AR-C 66096 tetrasodium salt
Potent and selective P2Y12 receptor antagonist. Blocks ADP-induced inhibition of adenylyl cyclase in vitro (pKB =7.6) and inhibits ADP-induced aggregation of washed human platelets (pIC50 = 8.16).
Sold for research purposes under agreement from AstraZeneca
|Storage||Store at -20°C|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
|Solubility||Soluble in water (supplied pre-dissolved at a concentration of 10mM)|
Preparing Stock Solutions
The following data is based on the product molecular weight 703.26. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|1 mM||1.42 mL||7.11 mL||14.22 mL|
|5 mM||0.28 mL||1.42 mL||2.84 mL|
|10 mM||0.14 mL||0.71 mL||1.42 mL|
|50 mM||0.03 mL||0.14 mL||0.28 mL|
The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.
References are publications that support the products' biological activity.
Humphries et al (1994) FPL 66096: a novel, highly potent and selective antagonist at human platelet P2T-purinoceptors. Br.J.Pharmacol. 113 1057 PMID: 7858849
Ingall et al (1999) Antagonists of the platelet P receptor: a novel approach to antithrombotic therapy. J.Med.Chem. 42 213 PMID: 9925726
Simon et al (2001) Activity of adenosine diphosphates and triphosphates on a P2YT-type receptor in brain capillary endothelial cells. Br.J.Pharmacol. 132 173 PMID: 11156575
If you know of a relevant reference for AR-C 66096 tetrasodium salt, please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: AR-C 66096 tetrasodium salt, supplier, FPL66096, AR-C66096, ARC66096, potent, selective, p2y12, purine, receptors, antagonist, purinoceptors, purinergic, p2yt, ARL66096, AstraZeneca, FPL, 66096, ARL, 66096, Purinergic, P2Y, Receptors, Purinergic, P2Y, Receptors, Tocris Bioscience
4 Citations for AR-C 66096 tetrasodium salt
Citations are publications that use Tocris products. Selected citations for AR-C 66096 tetrasodium salt include:
Zhang et al (2014) Agonist-bound structure of the human P2Y12 receptor. Purinergic Signal 509 119 PMID: 24784220
Helms et al (2013) Mechanisms of hemolysis-associated platelet activation. J Thromb Haemost 11 2148 PMID: 24119131
Pinheiro et al (2013) Bradykinin-induced Ca2+ signaling in human subcutaneous fibroblasts involves ATP release via hemichannels leading to P2Y12 receptors activation. Cell Commun Signal 11 70 PMID: 24047499
Gao et al (2013) The role of P2Y(14) and other P2Y receptors in degranulation of human LAD2 mast cells. Cell Commun Signal 9 31 PMID: 22825617
Do you know of a great paper that uses AR-C 66096 tetrasodium salt from Tocris? If so please let us know.